中国烧伤创疡杂志
中國燒傷創瘍雜誌
중국소상창양잡지
2014年
6期
429-432
,共4页
王洪生%徐礼笑子%李碧锦%杨毅%陈铮%李民
王洪生%徐禮笑子%李碧錦%楊毅%陳錚%李民
왕홍생%서례소자%리벽금%양의%진쟁%리민
烧伤%创疡%再生医学与疗法%Ⅳ期%压疮%疗效
燒傷%創瘍%再生醫學與療法%Ⅳ期%壓瘡%療效
소상%창양%재생의학여요법%Ⅳ기%압창%료효
Burns%Wounds and Ulcers%Regenerative Medicine and Therapy%PhaseⅣ%Pressure sores%Treat-ment Efficacy
目的:探索Ⅳ期压疮的有效治疗方法。方法46例Ⅳ期压疮患者在全身综合治疗的基础上全程采用烧伤创疡再生医学与疗法治疗创面,在彻底清除创面坏死组织后,用湿润烧伤膏药纱包扎治疗,每日换药1次,直至创面愈合,观察创面愈合效果。结果46例Ⅳ期压疮创面全部自行愈合,愈合时间最短30余天,最长150余天,平均愈合时间为(68?26±34?62) d;随访6~12个月,均未出现增生性瘢痕。结论烧伤创疡再生医学与疗法治疗Ⅳ期压疮疗效显著,在防治感染、缓解疼痛的同时,供给创面再生所需的营养物质,以促进创面愈合、减少瘢痕增生,值得临床推广应用。
目的:探索Ⅳ期壓瘡的有效治療方法。方法46例Ⅳ期壓瘡患者在全身綜閤治療的基礎上全程採用燒傷創瘍再生醫學與療法治療創麵,在徹底清除創麵壞死組織後,用濕潤燒傷膏藥紗包扎治療,每日換藥1次,直至創麵愈閤,觀察創麵愈閤效果。結果46例Ⅳ期壓瘡創麵全部自行愈閤,愈閤時間最短30餘天,最長150餘天,平均愈閤時間為(68?26±34?62) d;隨訪6~12箇月,均未齣現增生性瘢痕。結論燒傷創瘍再生醫學與療法治療Ⅳ期壓瘡療效顯著,在防治感染、緩解疼痛的同時,供給創麵再生所需的營養物質,以促進創麵愈閤、減少瘢痕增生,值得臨床推廣應用。
목적:탐색Ⅳ기압창적유효치료방법。방법46례Ⅳ기압창환자재전신종합치료적기출상전정채용소상창양재생의학여요법치료창면,재철저청제창면배사조직후,용습윤소상고약사포찰치료,매일환약1차,직지창면유합,관찰창면유합효과。결과46례Ⅳ기압창창면전부자행유합,유합시간최단30여천,최장150여천,평균유합시간위(68?26±34?62) d;수방6~12개월,균미출현증생성반흔。결론소상창양재생의학여요법치료Ⅳ기압창료효현저,재방치감염、완해동통적동시,공급창면재생소수적영양물질,이촉진창면유합、감소반흔증생,치득림상추엄응용。
Objective To explore effective treatment methods for pressure sores of phase Ⅳ. Method All 46 cases of patients with phase Ⅳ pressure sores were treated in the whole course with burns wounds and ulcers regenerative medicine and therapy on the basis of systemic comprehensive treatment. After thorough clean?up of necrotic tissues at wounds, MEBO gauze was bandaged once a day until the wounds healed and the healing effect was observed. Results All 46 cases healed automatically, with the shortest healing time of 30 days or soand the longest 150 days, averagely 68?26 ± 34?62 d;no hypertrophic scar was observed in 6 to 12 monthsfollow?up visit. Conclusion The effect of treating phaseⅣpressure sores with burns wounds and ulcers regenerative medicine and therapy issignificant. While alleviating and preven?ting infections and pains, regeneration requirednutrition substances are provided to wounds to promote wound healing and re?duce hypertrophic scar. This therapy is worth being promoted clinically.